These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 27159747

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Overview of high-risk medical device recalls in obstetrics and gynecology from 2002 through 2016: implications for device safety.
    Janetos TM, Ghobadi CW, Xu S, Walter JR.
    Am J Obstet Gynecol; 2017 Jul; 217(1):42-46.e1. PubMed ID: 28500861
    [Abstract] [Full Text] [Related]

  • 3. Assessment of Obstetric and Gynecologic Food and Drug Administration Device Approvals and Recalls.
    Galhotra S, Maurice J.
    J Minim Invasive Gynecol; 2018 Jul; 25(7):1281-1288. PubMed ID: 29653261
    [Abstract] [Full Text] [Related]

  • 4. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
    Gopal AD, Rathi VK, Teng CC, Del Priore L, Ross JS.
    Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK, Krumholz HM, Masoudi FA, Ross JS.
    JAMA; 2015 Aug 11; 314(6):604-12. PubMed ID: 26262798
    [Abstract] [Full Text] [Related]

  • 6. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
    Samuel AM, Rathi VK, Grauer JN, Ross JS.
    Clin Orthop Relat Res; 2016 Apr 11; 474(4):1053-68. PubMed ID: 26584802
    [Abstract] [Full Text] [Related]

  • 7. Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017.
    Dubin JR, Simon SD, Norrell K, Perera J, Gowen J, Cil A.
    JAMA Netw Open; 2021 May 03; 4(5):e217274. PubMed ID: 33956132
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessing the safety and effectiveness of devices after US Food and Drug Administration approval: FDA-mandated postapproval studies.
    Reynolds IS, Rising JP, Coukell AJ, Paulson KH, Redberg RF.
    JAMA Intern Med; 2014 Nov 03; 174(11):1773-9. PubMed ID: 25265209
    [Abstract] [Full Text] [Related]

  • 13. Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.
    Heneghan CJ, Goldacre B, Onakpoya I, Aronson JK, Jefferson T, Pluddemann A, Mahtani KR.
    BMJ Open; 2017 Dec 06; 7(12):e017125. PubMed ID: 29212782
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of FDA-Approved Orthopaedic Devices and Their Recalls.
    Day CS, Park DJ, Rozenshteyn FS, Owusu-Sarpong N, Gonzalez A.
    J Bone Joint Surg Am; 2016 Mar 16; 98(6):517-24. PubMed ID: 26984921
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review.
    Pease AM, Krumholz HM, Downing NS, Aminawung JA, Shah ND, Ross JS.
    BMJ; 2017 May 03; 357():j1680. PubMed ID: 28468750
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.